transitioning from tirzepatide to semaglutide Switching dosage chart Transitioning Treatments: What to Expect

Pregnant or breastfeeding individuals should not use semaglutide

A patient with lower GLP1R pathway activation might benefit more from tirzepatide's dual-peptide action (which targets both GLP-1 and GIP receptors), while someone with strong GLP1R sensitivity may achieve excellent results with standard semaglutide timing

Unlike subcutaneous fat that sits just beneath the skin, visceral fat surrounds vital organs such as the liver, pancreas, and intestines

That benefits patients everywhere, regardless of where they seek care, said Sandy Van, chief medical officer at Hims & Hers Canada

KPV is for patients whose inflammation isn't responding to conventional approaches

The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company